HEREDITARY ANGIOEDEMA
Clinical trials for HEREDITARY ANGIOEDEMA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill shows promise in preventing painful swelling attacks
Disease control CompletedThis study tested whether an oral medication called BCX4161 could safely prevent sudden swelling attacks in people with hereditary angioedema (HAE). For 12 weeks, 110 participants took either one of two doses of the pill or a placebo. Researchers measured how many attacks people …
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE2, PHASE3 • Sponsor: BioCryst Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New injection shows promise in Long-Term fight against rare swelling disorder
Disease control CompletedThis study tested the long-term safety and effectiveness of a drug called garadacimab for preventing attacks in people with hereditary angioedema (HAE), a rare genetic condition that causes severe, unpredictable swelling. It involved 171 participants aged 12 and older who had fre…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New hope for kids with rare swelling disorder
Disease control CompletedThis study tested the safety and effectiveness of a medication called sebetralstat (KVD900) in children aged 2 to 11 with hereditary angioedema (HAE), a rare genetic condition that causes sudden, severe swelling attacks. The trial involved 36 children and aimed to see how well th…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New pill shows promise for rapid relief from rare, painful swelling attacks
Symptom relief CompletedThis completed Phase 3 trial tested whether an oral capsule called deucrictibant could safely and quickly relieve sudden swelling attacks in people with hereditary angioedema (HAE). The study involved 134 participants aged 12 to 75 who took either the study drug or a placebo pill…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Study measures how fast emergency treatment works for rare swelling disorder
Symptom relief CompletedThis study observed 88 patients with hereditary angioedema (HAE) who already use icatibant to treat sudden swelling attacks. Researchers tracked how quickly symptoms improved and anxiety decreased after taking the medication. The goal was to better understand the real-world effec…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Symptom relief
Last updated Mar 02, 2026 15:27 UTC
-
New pill tested to stop painful swelling attacks
Symptom relief CompletedThis study tested an oral medication called deucrictibant for quickly relieving painful swelling attacks in people with hereditary angioedema (HAE). Seventy-four participants with HAE took either the study drug or a placebo pill at home when an attack started. Researchers measure…
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE2 • Sponsor: Pharvaris Netherlands B.V. • Aim: Symptom relief
Last updated Mar 02, 2026 15:22 UTC